NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum

2 days ago 5

Attiya Zainib

Mon, May 18, 2026 astatine 7:47 AM CDT 3 min read

Minot Light Capital Partners, an concern absorption company, released its “Capital Appreciation Fund" Q1 2026 Investor Letter. A transcript of the missive tin beryllium downloaded here. The money declined by 2.7% successful the archetypal 4th of 2026 owed to a crisp macro-driven assemblage rotation pursuing geopolitical tensions, which triggered ostentation fears and rising involvement complaint expectations. This script led to a displacement successful capitalist absorption toward sectors specified arsenic energy, defense, and AI-linked stocks, portion the fund’s halfway vulnerability to healthcare, consumer, and idiosyncratic industrials lagged. Despite this setback, the steadfast maintains a constructive semipermanent outlook, suggesting that the existent marketplace volatility and consensus-driven marketplace narratives are creating charismatic opportunities successful out-of-favor sectors wherever it continues to find compelling valuations and expects eventual mean reversion to thrust aboriginal returns.  In addition, you tin cheque the Fund’s apical 5 holdings to find its champion picks for 2026.

In its first-quarter 2026 capitalist letter, Minot Light Capital Appreciation Fund highlighted stocks similar NeurAxis, Inc. (NYSEAMERICAN:NRXS). NeurAxis, Inc. (NYSEAMERICAN:NRXS) is simply a aesculapian exertion institution processing neuromodulation therapies for chronic and functional disorders. The one-month instrumentality of NeurAxis, Inc. (NYSEAMERICAN:NRXS) was 12.43% portion its shares traded betwixt $2.07 and $9.33 implicit the past 52 weeks. On May 15, 2026, NeurAxis, Inc. (NYSEAMERICAN:NRXS) banal closed astatine astir $7.87 per share, with a marketplace capitalization of astir $97.46 million.

Minot Light Capital Appreciation Fund stated the pursuing regarding NeurAxis, Inc. (NYSEAMERICAN:NRXS) successful its Q1 2026 capitalist letter:

"In general, our apical 5 contributors to the portfolio this 4th correspond a bully premix of emerging growth, halfway growth, and heavy worth holdings. NeurAxis, Inc. (NYSEAMERICAN:NRXS) is 1 of them. Neuraxis (NRXS), an emerging maturation aesculapian instrumentality institution astatine the earliest stages of commercialization that is presently benefitting from caller inclusion into manufacture guidelines and reimbursement progress.

NeurAxis, Inc. (NRXS) Climbs connected  Reimbursement and Guideline Momentum

NeurAxis, Inc. (NRXS) Climbs connected Reimbursement and Guideline Momentum

create jobs 51/Shutterstock.com

NeurAxis, Inc. (NYSEAMERICAN:NRXS) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. As per our database, 2 hedge money portfolios held NeurAxis, Inc. (NYSEAMERICAN:NRXS) astatine the extremity of the 4th quarter, which was 2 successful the erstwhile quarter. While we admit the hazard and imaginable of NeurAxis, Inc. (NYSEAMERICAN:NRXS) arsenic an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and doing truthful wrong a shorter clip frame. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article